MA
NVO icon

Mutual Advisors’s Novo Nordisk NVO Stock Holding History

Mutual Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.77M Buy
73,037
+620
+0.9% +$28.6K 0.05% 346
2026
Q2 		$3.47M Buy
72,417
+2,960
+4% +$127K 0.07% 287
2026
Q1 		$2.55M Buy
69,457
+20,934
+43% +$992K 0.05% 324
2025
Q4 		$2.47M Buy
48,523
+933
+2% +$47.7K 0.05% 316
2025
Q3 		$2.53M Buy
47,590
+2,272
+5% +$133K 0.06% 303
2025
Q2 		$3.25M Buy
45,318
+7,469
+20% +$508K 0.08% 233
2025
Q1 		$2.35M Buy
37,849
+9,622
+34% +$795K 0.07% 252
2024
Q4 		$2.34M Sell
28,227
-3,317
-11% -$359K 0.07% 250
2024
Q3 		$3.59M Buy
31,544
+1,871
+6% +$250K 0.11% 178
2024
Q2 		$3.8M Buy
29,673
+2,384
+9% +$316K 0.11% 171
2024
Q1 		$3.5M Buy
27,289
+894
+3% +$106K 0.11% 167
2023
Q4 		$2.73M Buy
26,395
+1,363
+5% +$135K 0.1% 209
2023
Q3 		$2.28M Sell
25,032
-5,000
-17% -$440K 0.09% 215
2023
Q2 		$2.43M Buy
30,032
+2,770
+10% +$226K 0.09% 220
2023
Q1 		$2.17M Sell
27,262
-6,538
-19% -$464K 0.09% 228
2022
Q4 		$2.29M Sell
33,800
-1,692
-5% -$99.2K 0.1% 200
2022
Q3 		$1.77M Buy
35,492
+26,138
+279% +$1.4M 0.09% 212
2022
Q2 		$521K Sell
9,354
-232
-2% -$12.9K 0.03% 521
2022
Q1 		$532K Buy
9,586
+1,468
+18% +$75.3K 0.03% 559
2021
Q4 		$455K Buy
8,118
+1,754
+28% +$95K 0.02% 609
2021
Q3 		$306K Sell
6,364
-960
-13% -$46.4K 0.02% 708
2021
Q2 		$307K Buy
7,324
+174
+2% +$6.74K 0.02% 678
2021
Q1 		$241K Sell
7,150
-23,426
-77% -$834K 0.02% 681
2020
Q4 		$1.07M Sell
30,576
-8,370
-21% -$289K 0.08% 290
2020
Q3 		$1.35M Sell
38,946
-1,418
-4% -$47.3K 0.12% 194
2020
Q2 		$1.32M Buy
40,364
+29,534
+273% +$942K 0.13% 180
2020
Q1 		$326K Buy
10,830
+522
+5% +$15.5K 0.04% 378
2019
Q4 		$298K Buy
10,308
+1,002
+11% +$27.7K 0.03% 463
2019
Q3 		$241K Buy
+9,306
New +$235K 0.03% 465
2019
Q1 		– Sell
-12,800
Closed -$295K – 491
2018
Q4 		$295K Buy
+12,800
New +$284K 0.06% 331

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Folketrygdfondet
Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Mutual Advisors's NVO Position: Q3 2026 in Review

Mutual Advisors increased its Novo Nordisk (NVO) stake by 0.86% in Q3 2026, buying an estimated $28.6K and bringing the position to 73,037 shares worth $2.77M. The position accounts for 0.05% of the portfolio, ranked #346.

Mutual Advisors first reported a position in NVO in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.8M in Q2 2024. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Mutual Advisors held 73,037 shares of Novo Nordisk worth $2.77M as of Q3 2026.
  • Mutual Advisors bought 620 Novo Nordisk shares in Q3 2026, an estimated $28.6K.
  • Novo Nordisk made up 0.05% of Mutual Advisors's portfolio in Q3 2026, its #346 holding.
  • Mutual Advisors first reported a position in Novo Nordisk in Q4 2018 and has held it in 30 quarters since.
  • Mutual Advisors's Novo Nordisk position peaked at $3.8M in Q2 2024.
  • 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Mutual Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.